Setyo Teguh Waluyo

Setyo Teguh Waluyo

Auto-generated profile, based on publicly available information

Setyo Teguh Waluyo

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Lambung Mangkurat University, Ulin General Hospital, Banjarmasin, Indonesia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in Bali Medical Journal
Verified
Journal Article
Open access
PDF file
SWSetyo Teguh Waluyo
Setyo Teguh Waluyo
BTBrahmana Askandar Tjokroprawiro
Brahmana Askandar Tjokroprawiro
Background: Borderline ovarian tumors (BOT) are a subset of epithelial neoplasms histologically defined as atypical epithelial proliferation without stromal invasion. BOTs account for 10-20% of ovarian cancer cases. This study aims to know the clinical and pathological characteristics and determine the differences in these characteristics based on age classification. Methods: A 5-year retrospective study was conducted in a single center. Information was obtained from the pathological reports of 53 patients with BOTs between 2016-2021. Statistical analysis was performed using the Student’s t-test with SPSS version 20.0 (SPSS Inc). Continuous data were analyzed using t-tests, and categorical data were tested with Chi-square or Fisher's exact test to assess differences in clinical and pathological features between the 40 years age groups Results: Most of the tumor diameters were >10 cm (92.45%) and 40 years group than in the < 40 years group (p 0.05). The mean CA 125 level was higher in the >40 years group (257.92± 64.35) than in the <40 years group (74.42±63.02) (p < 0.05). Conclusion: The median age of BOT was 40 years old and the majority had a large unilateral tumor with mucinous, the most common histologic type. There was a correlation between age, SBOT histologic type, and elevated CA-125.

14 October 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
FEFebia Erfiandi
Febia Erfiandi
SWSetyo Teguh Waluyo
Setyo Teguh Waluyo
CSCandra Novi Ricardo Sibarani
Candra Novi Ricardo Sibarani
GWGatot Nyarumenteng Adhipurnawan Winarno
Gatot Nyarumenteng Adhipurnawan Winarno
AHAini Sofa Haniah
Aini Sofa Haniah
NANicholas Adrianto
Nicholas Adrianto
Objective: This systematic review and meta-analysis evaluate the efficacy and safety of salvage regimens in managing EMA/CO-resistant GTN, providing evidence to inform optimal treatment strategies. Methods: A literature search was conducted in PubMed, ScienceDirect, Cochrane Library, Google Scholar, and Wiley Online Library until December 27, 2024. Studies on EMA/CO chemoresistance in gestational trophoblastic neoplasia (GTN) were included, and alternative regimens and surgical interventions were also considered. Exclusion applied to non-human studies and those unrelated to EMA/CO chemoresistance. Data extraction and quality assessment followed PRISMA, Cochrane ROB-2, and the Newcastle-Ottawa Scale. A meta-analysis was performed using a random-effects model, with heterogeneity (I²) and publication bias assessed. The study was registered with PROSPERO (CRD42024574582). Results: Eight studies met the inclusion criteria, encompassing patients predominantly with advanced-stage (FIGO III-IV) and high-risk GTN. EMA/EP and EP/EMA were the most frequently evaluated salvage regimens, with a pooled complete remission rate of 78.7% (95% CI: 67.4–88.1%) across 84 patients. No significant heterogeneity (I² = 27.05%) or publication bias was detected. Alternative regimens, including BEP, FAEV, and TP/TE, demonstrated favourable remission rates in small cohorts but lacked generalizability. Neutropenia (68%), thrombocytopenia (41%), and anaemia (30%) were the most commonly reported toxicities with EP/EMA. Safety data for other regimens were limited. Conclusion: EMA/EP and EP/EMA remain the most effective and well-studied salvage regimens for EMA/CO-resistant GTN, demonstrating high remission rates with manageable toxicity. While alternative regimens such as BEP, FAEV, and TP/TE show encouraging results, their limited evidence base precludes definitive comparison. Further prospective studies are needed to establish optimal salvage strategies and refine toxicity management.

29 August 2023 in Majalah Obstetri & Ginekologi
Verified
Journal Article
Open access
PDF file
SWSetyo Teguh Waluyo
Setyo Teguh Waluyo
FAFerry Armanza
Ferry Armanza
HYHariadi Yuseran
Hariadi Yuseran
KHKevin Stanley Halim
Kevin Stanley Halim
HIGHLIGHTS ABSTRACT Objective: The aim of this study was to investigate the characteristics of the Gynecology Oncology Outpatient Clinic at Ulin Hospital Banjarmasin before and after the COVID-19 pandemic. Materials and Methods: This descriptive study utilized existing patient data from the Gynecology Oncology Outpatient Clinic at Ulin Hospital Banjarmasin covering the period from March 2019 to February 2021. The study received ethical approval from the Ulin General Hospital ethics committee with clearance number 10/I-Reg Research/RSUDU/23. The collected data was presented in a tabular format to compare the service characteristics before the pandemic (March 2019 - February 2020) and after the pandemic (March 2020 – February 2021). Results: During the periods of March 2019 – February 2020 and March 2020 – February 2021, there was a reduction of 19% in patient visits. The number of patients undergoing treatment also decreased, from 1081 patients (53.9%) in the period of March 2019 – February 2020 to 926 patients (46.1%) in the period of March 2020 – February 2021. Notably, there was a decrease in the number of patients undergoing surgical procedures, dropping from 76 patients (70.4%) in the period of March 2019 – February 2020 to 32 patients (29.6%) in the period of March 2020 – February 2021. A similar trend was seen in patients receiving chemotherapy, with the count decreasing from 1005 patients (52.9%) in the period of March 2019 – February 2020 to 894 patients (47.1%) in the period of March 2020 – February 2021. These changes were attributed to various hospital measures implemented to address the COVID-19 pandemic, including a reduction in outpatient clinic visits and the temporary suspension of surgical procedures from March 2020 to October 2020 to minimize potential exposure. Conclusion: The study highlights a noticeable decline in both the frequency of visits to the Gynecology Oncology Outpatient Clinic at Ulin Regional General Hospital Banjarmasin and the number of patients receiving treatment during the periods before and after the onset of the COVID-19 pandemic.

17 October 2026 in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Verified
Journal Article
Open access
SWSetyo Teguh Waluyo
Setyo Teguh Waluyo
BTBrahmana Askandar Tjopkroprawiro
Brahmana Askandar Tjopkroprawiro
PWPeng-Hui Wang
Peng-Hui Wang
WWWidjiati Widjiati
Widjiati Widjiati

24 April 2025 in American Journal of Case Reports
Verified
Journal Article
Open access
SWSetyo Teguh Waluyo
Setyo Teguh Waluyo
HYHariadi Yuseran
Hariadi Yuseran
FAFerry Armanza
Ferry Armanza
FMFendy Frans Elya Cohen Manalu
Fendy Frans Elya Cohen Manalu
BACKGROUND Botryoid rhabdomyosarcoma is a subtype of embryonal rhabdomyosarcoma and is a rare and highly vascular malignant childhood tumor, with the most common sites of origin being the vagina and cervix in young girls. This report describes the case of a 15-year-old girl presenting with vaginal hemorrhage due to botryoid rhabdomyosarcoma treated with emergency radiation therapy. Hemorrhage in botryoid rhabdomyosarcoma can present as a life-threatening emergency requiring immediate intervention. This case highlights the role of emergency external radiation therapy as a valuable adjunct in managing hemorrhage in botryoid rhabdomyosarcoma, especially when surgical options are limited. CASE REPORT We report a case of a 15-year-old girl who experienced repeated profuse episodes of vaginal bleeding and protruding mass in the vagina for 2 months. She had no significant medical history or family history of cancer. Magnetic resonance imaging (MRI) confirmed a massive malignant mass in the vaginal introitus that infiltrated the cervix, extending to the uterus. Based on the histopathology result, the diagnosis was botryoid rhabdomyosarcoma with a primary site located on the cervix, and due to the emergency situation and the risks associated with surgical intervention, emergency external radiation therapy was initiated. After 1 session of radiation therapy, the bleeding was significantly reduced. CONCLUSIONS Hemorrhage in botryoid rhabdomyosarcoma is a rare but critical complication. Emergency external radiation therapy helps stabilize the patient with acute bleeding caused by botryoid rhabdomyosarcoma. Further research is needed to find the optimal treatment strategies.